The global endoscopic ultrasonography (EUS) market is projected to grow from USD 1.37 billion in 2024 to USD 1.93 billion by 2029, at a CAGR of 7.1% during the forecast period. Market growth is primarily driven by the increasing prevalence of gastrointestinal diseases, rising demand for minimally invasive procedures, and ongoing technological advancements in imaging and endoscopic systems.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19121066
EUS has become a critical tool in modern diagnostics and therapeutics, particularly in oncology and gastrointestinal care, offering high-resolution imaging and enabling precise tissue sampling. Growing awareness regarding early disease detection and expanding healthcare infrastructure are further supporting adoption globally. However, high procedure costs and certain technical limitations may restrain market growth.
Endoscopes Segment Leads the Market by Product
Based on product, the endoscopes segment is expected to account for the largest share of the EUS market during the forecast period. This dominance is driven by the growing adoption of minimally invasive procedures and the increasing use of endoscopes in both diagnostic and therapeutic applications, including tumor detection, cancer staging, and fine-needle aspiration.
Continuous advancements in endoscopic technologies, including improved imaging quality and enhanced maneuverability, are further strengthening the segment’s position.
Therapeutic Segment Gains Momentum
By type, the therapeutic segment holds the second-largest share of the market. Growth in this segment is attributed to the increasing use of EUS in the management of cancers, gastrointestinal lesions, and chronic pancreatitis.
Technological improvements such as high-resolution visualization systems and advanced needle designs are enhancing procedural efficiency and expanding the therapeutic applications of EUS.
Oncology Segment Dominates by Application
The oncology segment is expected to account for the largest share of the EUS market by application. EUS is widely used for cancer staging and diagnosis, particularly in gastric, pancreatic, rectal, and esophageal cancers.
Advancements such as elastography and high-resolution imaging are improving diagnostic accuracy and enabling better clinical decision-making, thereby driving adoption in oncology.
Ambulatory Surgery Centers Witness Growing Adoption
Among end users, ambulatory surgery centers (ASCs) hold the second-largest market share. The shift toward outpatient procedures, driven by cost-effectiveness and convenience, is fueling the adoption of EUS systems in these settings.
As the demand for minimally invasive procedures continues to rise, ASCs are expected to play an increasingly important role in market growth.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=19121066
Europe Holds Second-Largest Regional Share
Europe is expected to account for the second-largest share of the global EUS market during the forecast period. Growth in the region is supported by increasing investments in healthcare infrastructure, high adoption of advanced medical technologies, and a rising prevalence of gastrointestinal diseases.
These factors are driving demand for advanced endoscopic imaging solutions across the region.
Competitive Landscape
Key players in the endoscopic ultrasonography market include Olympus Corporation, Medtronic, FUJIFILM Holdings Corporation, Boston Scientific Corporation, PENTAX Medical, Steris, CONMED Corporation, CANON MEDICAL SYSTEMS CORPORATION, Cook, SonoScape Medical Corp., Endosound, Inc., and other emerging and regional players.
These companies are focusing on technological innovation, product development, and strategic collaborations to strengthen their market presence and expand their global footprint.
